Opus Genetics(DE:R3X1)
€3.62+0.06 (+1.69%)
DE:R3X1
Opus Genetics financials statements
€3.62
At close:+0.06 (+1.69%)
Opus Genetics (R3X1) Financial Statements
3 Followers
Opus Genetics Financial Overview
Opus Genetics's market cap is currently $349.00M. The company's EPS TTM is $-1.53; its P/E ratio is -2.60; Opus Genetics is estimated to report earnings on March 11, 2027, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.20M | $ 10.99M | $ 19.05M | $ 39.85M | $ 589.00K |
| Gross Profit | $ 14.20M | $ 10.99M | $ 19.05M | $ 39.85M | $ 589.00K |
| Operating Income | $ -38.60M | $ -62.07M | $ -10.56M | $ 18.23M | $ -22.70M |
| EBITDA | $ -48.07M | $ -57.52M | $ -9.97M | $ 18.22M | $ -56.69M |
| Net Income | $ -49.59M | $ -57.53M | $ -9.99M | $ 17.89M | $ -56.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 45.09M | $ 30.32M | $ 50.52M | $ 42.68M | $ 24.75M |
| Total Assets | $ 50.24M | $ 36.86M | $ 53.95M | $ 48.99M | $ 26.08M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 538.00K |
| Net Debt | $ -45.09M | $ -30.32M | $ -50.50M | $ -42.63M | $ -24.00M |
| Total Liabilities | $ 34.90M | $ 30.14M | $ 4.04M | $ 2.75M | $ 3.85M |
| Stockholders' Equity | $ 15.35M | $ 6.72M | $ 49.91M | $ 46.24M | $ 22.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.25M | $ -25.58M | $ -1.11M | $ 14.31M | $ -19.37M |
| Operating Cash Flow | $ -35.25M | $ -25.58M | $ -1.11M | $ 14.31M | $ -19.37M |
| Investing Cash Flow | $ 0.00 | $ 1.21M | $ 0.00 | $ 0.00 | $ -100.00K |
| Financing Cash Flow | $ 50.02M | $ 4.19M | $ 8.98M | $ 3.79M | $ 27.61M |
Currency in USD

